| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $88M | ||
| $62M |
Buys | $0 | 0 | 0 |
Sells | $11,347,844 | 48 | 100 |
| Manni Joseph S. | Chief Revenue Officer | 0 | $0 | 1 | $15,199 | $-15,199 |
| Taylor Joseph Michael | director | 0 | $0 | 1 | $82,696 | $-82,696 |
| Foehr David | Senior VP, Finance and PAO | 0 | $0 | 7 | $185,553 | $-185,553 |
| Blumberg Scott | Chief Financial Officer | 0 | $0 | 2 | $430,089 | $-430,089 |
| BURKE WILLIAM W | director | 0 | $0 | 1 | $506,460 | $-506,460 |
| ROBERTSON REBECCA B | director | 0 | $0 | 8 | $866,388 | $-866,388 |
| Woo Raymond | Chief Technology Officer | 0 | $0 | 8 | $1.2M | $-1.2M |
| Parvizi Josef | director | 0 | $0 | 6 | $2.12M | $-2.12M |
| Chao Xingjuan | President and CEO | 0 | $0 | 14 | $5.94M | $-5.94M |
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
Over the last 12 months, insiders at CeriBell, Inc. have bought $0 and sold $11.35M worth of CeriBell, Inc. stock.
On average, over the past 5 years, insiders at CeriBell, Inc. have bought $0 and sold $11.35M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
| 2026-03-03 | Sale | Chao Xingjuan | President and CEO | 25,000 0.0648% | $17.45 | $436,264 | +4.22% | |
| 2026-03-03 | Sale | ROBERTSON REBECCA B | director | 827 0.0022% | $17.80 | $14,721 | +4.22% | |
| 2026-03-03 | Sale | Foehr David | Senior VP, Finance and PAO | 1,157 0.0031% | $17.80 | $20,595 | +4.22% | |
| 2026-03-02 | Sale | Woo Raymond | Chief Technology Officer | 11,112 0.0293% | $18.25 | $202,839 | -0.34% | |
| 2026-02-24 | Sale | Foehr David | Senior VP, Finance and PAO | 781 0.0021% | $19.98 | $15,604 | -8.02% | |
| 2026-02-23 | Sale | Chao Xingjuan | President and CEO | 2,084 0.0056% | $19.79 | $41,242 | -8.30% | |
| 2026-02-23 | Sale | Woo Raymond | Chief Technology Officer | 705 0.0019% | $19.79 | $13,952 | -8.30% | |
| 2026-02-23 | Sale | Blumberg Scott | Chief Financial Officer | 808 0.0022% | $19.79 | $15,990 | -8.30% | |
| 2026-02-23 | Sale | Manni Joseph S. | Chief Revenue Officer | 768 0.002% | $19.79 | $15,199 | -8.30% | |
| 2026-02-23 | Sale | Foehr David | Senior VP, Finance and PAO | 569 0.0015% | $19.79 | $11,261 | -8.30% | |
| 2026-02-19 | Sale | Parvizi Josef | director | 16,714 0.0458% | $20.27 | $338,793 | -9.41% | |
| 2026-02-18 | Sale | Parvizi Josef | director | 6,986 0.0189% | $20.00 | $139,720 | -7.07% | |
| 2026-02-17 | Sale | Parvizi Josef | director | 1,300 0.0036% | $20.00 | $26,000 | -5.18% | |
| 2026-02-04 | Sale | Chao Xingjuan | President and CEO | 23,554 0.0635% | $20.16 | $474,849 | -3.77% | |
| 2026-02-03 | Sale | Foehr David | Senior VP, Finance and PAO | 2,153 0.0057% | $20.00 | $43,060 | -5.32% | |
| 2026-02-02 | Sale | Woo Raymond | Chief Technology Officer | 9,640 0.0264% | $20.55 | $198,096 | -4.10% | |
| 2026-01-15 | Sale | Parvizi Josef | director | 25,000 0.0677% | $22.94 | $573,500 | -12.59% | |
| 2026-01-05 | Sale | Chao Xingjuan | President and CEO | 79,000 0.2025% | $21.27 | $1.68M | -2.84% | |
| 2026-01-05 | Sale | Foehr David | Senior VP, Finance and PAO | 2,153 0.0059% | $22.60 | $48,658 | -2.84% | |
| 2026-01-02 | Sale | Woo Raymond | Chief Technology Officer | 11,112 – | $21.18 | $235,382 | -5.07% |
| Increased Positions | 79 | +77.45% | 6M | +22.79% |
| Decreased Positions | 45 | -44.12% | 4M | -15.29% |
| New Positions | 38 | New | 3M | New |
| Sold Out Positions | 20 | Sold Out | 1M | Sold Out |
| Total Postitions | 136 | +33.33% | 28M | +7.5% |